SMITH & NEPHEW PLC -SPON ADR (SNN) Stock Price, Forecast & Analysis
USA - NYSE:SNN - US83175M2052 - ADR
SNN Key Statistics, Chart & Performance
The current stock price of SNN is 32.69 USD. In the past month the price decreased by -10.04%. In the past year, price increased by 31.34%.
SNN Latest News, Press Relases and Analysis
SNN Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 26.17 | 227.29B | ||
| ISRG | INTUITIVE SURGICAL INC | 63.82 | 196.99B | ||
| BSX | BOSTON SCIENTIFIC CORP | 34.81 | 152.16B | ||
| SYK | STRYKER CORP | 27.5 | 138.48B | ||
| BDX | BECTON DICKINSON AND CO | 13.39 | 55.33B | ||
| IDXX | IDEXX LABORATORIES INC | 54.71 | 55.19B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.58 | 50.67B | ||
| RMD | RESMED INC | 24.69 | 35.68B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.94 | 33.40B | ||
| PODD | INSULET CORP | 72.8 | 23.42B | ||
| DXCM | DEXCOM INC | 31.22 | 22.77B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.11 | 17.81B |
Related stock screener links
About SNN
Company Profile
Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. The company is headquartered in Watford, Hertfordshire and currently employs 17,000 full-time employees. The firm is engaged in developing, manufacturing, marketing, and selling medical devices and services. The company is focused on the repair, regeneration, and replacement of soft and hard tissue. The firm's segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilise severe fractures and correct bone deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
Company Info
SMITH & NEPHEW PLC -SPON ADR
Building 5, Croxley Park, Hatters Lane
Watford HERTFORDSHIRE WD18 8YE GB
CEO: Roland Diggelmann
Employees: 17349
Phone: 4401923477100
SMITH & NEPHEW PLC -SPON ADR / SNN FAQ
Can you describe the business of SMITH & NEPHEW PLC -SPON ADR?
Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. The company is headquartered in Watford, Hertfordshire and currently employs 17,000 full-time employees. The firm is engaged in developing, manufacturing, marketing, and selling medical devices and services. The company is focused on the repair, regeneration, and replacement of soft and hard tissue. The firm's segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilise severe fractures and correct bone deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
What is the stock price of SMITH & NEPHEW PLC -SPON ADR today?
The current stock price of SNN is 32.69 USD. The price decreased by -0.85% in the last trading session.
Does SNN stock pay dividends?
SMITH & NEPHEW PLC -SPON ADR (SNN) has a dividend yield of 2.27%. The yearly dividend amount is currently 0.37.
How is the ChartMill rating for SMITH & NEPHEW PLC -SPON ADR?
SNN has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
What is the ex-dividend date for SNN stock?
The next ex-dividend date for SMITH & NEPHEW PLC -SPON ADR (SNN) is October 3, 2025.
Should I buy SNN stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on SNN.
What is the Short Interest ratio of SMITH & NEPHEW PLC -SPON ADR (SNN) stock?
The outstanding short interest for SMITH & NEPHEW PLC -SPON ADR (SNN) is 0.6% of its float.
SNN Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to SNN. When comparing the yearly performance of all stocks, SNN is one of the better performing stocks in the market, outperforming 73.61% of all stocks.
SNN Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to SNN. SNN has an excellent profitability rating, but there are some minor concerns on its financial health.
SNN Financial Highlights
Over the last trailing twelve months SNN reported a non-GAAP Earnings per Share(EPS) of 1.16. The EPS increased by 59.86% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 8.26% | ||
| ROA | 4.59% | ||
| ROE | 8.87% | ||
| Debt/Equity | 0.6 |
SNN Forecast & Estimates
23 analysts have analysed SNN and the average price target is 38.64 USD. This implies a price increase of 18.2% is expected in the next year compared to the current price of 32.69.
For the next year, analysts expect an EPS growth of 28.32% and a revenue growth 6.38% for SNN